Adiponectin is an adipose tissue-derived plasma protein which has a reduced concentration in subjects with obesity-related diseases. Adiponectin has antidiabetic and anti-inflammatory characteristics, which lead to beneficial actions on various obesity-linked complications. Recent experimental findings have shown that adiponectin contributes to protection against cardiac remodelling after pressure overload and cardiac injury following ischaemia-reperfusion. Thus, adiponectin could emerge as a potential cardioprotective agent for the treatment of several pathological heart conditions.
Targeting adiponectin for cardioprotection. Publishing Authors By Initials
Targeting adiponectin for cardioprotection. Journal Published:
PUBLICATION TYPE: Review
Journal: Expert opinion on therapeutic targets
VOLUME: 10
Page Numbers: 573-81
Journal Abbreviation:
ISSN: 1744-7631
DAY: 3
MONTH: Aug
YEAR: 2006
Targeting adiponectin for cardioprotection. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101127833
Targeting adiponectin for cardioprotection. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Targeting adiponectin for cardioprotection. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Targeting adiponectin for cardioprotection.
AFFILIATION: Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany Street, W611, Boston, MA 02118, USA.
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Expert Opin Ther Targets
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Targeting adiponectin for cardioprotection Related Publications